All AbMole products are for research use only, cannot be used for human consumption.
2-methoxyestradiol (2-ME2), an endogenous metabolite of 17β -estradiol (E2) with oral activity, is an apoptosis inducer and angiogenesis inhibitor with effective antitumor activity. Methoxyestradiol can also destabilize microtubules. Methoxyestradiol is a potent inhibitor of superoxide dismutase (SOD) and reactive oxygen species (ROS) that can induce autophagy in transformed cell line HEK293, cancer cell line U87 and HeLa.
Sci Rep. 2016 Jul 1;6:28612.
Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.
2-Methoxyestradiol purchased from AbMole
_figure5_2-methoxyestradiol(2-me).jpg) |
Source | Sci Rep (2016). Figure 5. 2-methoxyestradiol (2-ME) was purchased from Abmole |
| Method | CHIP assay and Immunohistochemistry staining | |
| Cell Lines | in vivo experiment | |
| Concentrations | 25mg/kg daily | |
| Incubation Time | 30 days | |
| Results | Administration of 2-ME and digoxin significantly decreased AngII- mediated HIF-1α, VEGF, MMP-2 and MMP-9 overexpression in the homogenates of the whole aortas, as shown in Fig. 5A. 2-ME and digoxin decreased the AngII induced HIF-1α levels accumulation and elastin degradation in the aorta (Fig. 5B). |
_figure4_2-methoxyestradiol(2-me).jpg) |
Source | Sci Rep (2016). Figure 4. 2-methoxyestradiol (2-ME) was purchased from Abmole |
| Method | in vivo experiment | |
| Cell Lines | ||
| Concentrations | 25mg/kg daily | |
| Incubation Time | 30 days | |
| Results | Both non-selective HIF-1α inhibitors 2-ME (25 mg/kg/day, s.c.) and digoxin (1.25 mg/kg/day, i.p.) significantly improved the survival rates (log rank test, n= 20 in each group, p < 0.05, Fig. 4B); decreased the incidences of AAA (0% vs. 84% vs. 35%, vs. 40%, p < 0.01, Fig. 4C), the severities of AAA, in terms of less type III and type IV lesions (43% vs. 15%, vs. 15%, p < 0.05, Fig. 4D) and the external diameters of the aorta (0.67 ± 0.11 mm vs. 1.68.± 0.77 vs. 0.96± 0.30 vs. 1.10± 0.53 mm, p< 0.05, Fig. 4E). |
_figure3_2-methoxyestradiol(2-me).jpg) |
Source | Sci Rep (2016). Figure 3. 2-methoxyestradiol (2-ME) was purchased from Abmole |
| Method | CHIP assay | |
| Cell Lines | HAECs | |
| Concentrations | 6 μM | |
| Incubation Time | 30 min | |
| Results | We found that both 2-ME and digoxin attenuated AngII and oxPAPC induced up-regulation of MMP-2 and MMP-9 (n = 5, Fig. 3) |
| Cell Experiment | |
|---|---|
| Cell lines | MCF-7 and MDA-MB-231 cells |
| Preparation method | Cell culture and cell treatment. MCF-7 estrogen receptor-positive (ER+ve) human breast cancer cells, MDA-MB-231 ER-negative (ER−ve) human breast cancer cells were obtained from the American Type Culture Collection (LGC Promochem, Teddington, UK). Cells were routinely cultured in RPMI-1640 medium supplemented with 10% (v/v) fetal calf serum, 1% L-glutamine (200 mM), 1% non-essential amino acids (100 ×) and 1% bicarbonate (7.5%) from Sigma and maintained in a humidified incubator under 5% CO2 atmosphere at 37°C. For experiments using hypoxic conditions, cells were incubated under 1% O2 and 5% CO2 atmosphere at 37°C. |
| Concentrations | 0.5 μM |
| Incubation time | 18 h |
| Animal Experiment | |
|---|---|
| Animal models | mice bearing MCF-7 and MDA-MB-231 xenografts model |
| Formulation | 10% tetrahydrofuran: 90% propylene glycol |
| Dosages | 40 or 75 mg/kg |
| Administration | orally daily for 28 days |
| Molecular Weight | 302.41 |
| Formula | C19H26O3 |
| CAS Number | 362-07-2 |
| Solubility (25°C) | DMSO ≥ 60 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Lakhani NJ, et al. Pharmacotherapy. 2-Methoxyestradiol, a promising anticancer agent.
| Related HIF Products |
|---|
| HIF-1α-IN-3
HIF-1α-IN-3 is a hypoxia-selective HIF-1α inhibitor. |
| HIF-2α-IN-2
HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor, has an IC50 of 16 nM in scintillation proximity assay (SPA). |
| PRLX-93936 dihydrochloride
PRLX-93936 dihydrochloride is a HIF-1α inhibitor with anticancer activity. |
| 3-Aminobenzoic acid
3-Aminobenzoic acid is a hypoxia-inducible factor-1α (HIF-1α) inhibitor. |
| Steppogenin
Steppogenin is a potent inhibitor of HIF-1α and DLL4, with IC50 values of 0.56 and 8.46 μM, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
